Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Kailash Krishnan, Zhe Kang Law, Jatinder S Minhas, Philip M Bath, Thompson G Robinson, Nikola Sprigg, Akash Mavilakandy, Timothy J England, David Eveson, Amit Mistri, Jesse Dawson and Jason P Appleton
DOI: https://doi.org/10.7861/clinmed.2021-0597
Clin Med September 2022 Kailash Krishnan
AQueen's Medical Centre, Nottingham, UK
Roles: consultant in stroke medicine
Zhe Kang Law
BNational University of Malaysia, Kuala Lumpur, Malaysia
Roles: consultant in neurology
Jatinder S Minhas
CUniversity of Leicester, Leicester, UK and Leicester Royal Infirmary, Leicester, UK
Roles: consultant in stroke medicine
Philip M Bath
DQueen's Medical Centre, Nottingham, UK
Roles: stroke association professor of stroke medicine and honorary consultant physician
Thompson G Robinson
EUniversity of Leicester, Leicester, UK and Leicester Royal Infirmary, Leicester, UK
Roles: professor of stroke medicine
Nikola Sprigg
FQueen's Medical Centre, Nottingham, UK
Roles: professor of stroke medicine
Akash Mavilakandy
GUniversity of Leicester, Leicester, UK
Roles: academic foundation year-2 trainee
Timothy J England
HQueen's Medical Centre, Nottingham, UK and Royal Derby Hospital, Derby, UK
Roles: professor of stroke medicine
David Eveson
ILeicester Royal Infirmary, Leicester, UK
Roles: consultant in stroke medicine
Amit Mistri
JLeicester Royal Infirmary, Leicester, UK
Roles: consultant in stroke medicine
Jesse Dawson
KUniversity of Glasgow College of Medical, Veterinary and Life Sciences, Glasgow, UK and Queen Elizabeth University Hospital, Glasgow, UK
Roles: professor of stroke medicine
Jason P Appleton
LQueen Elizabeth Hospital, Birmingham, UK and University of Birmingham College of Dental and Medical Sciences, Birmingham, UK
Roles: consultant in neurology
Article Figures & Data
Tables
Additional Files
Supplementary material
Files in this Data Supplement:
Article Tools
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Kailash Krishnan, Zhe Kang Law, Jatinder S Minhas, Philip M Bath, Thompson G Robinson, Nikola Sprigg, Akash Mavilakandy, Timothy J England, David Eveson, Amit Mistri, Jesse Dawson, Jason P Appleton
Clinical Medicine Sep 2022, 22 (5) 449-454; DOI: 10.7861/clinmed.2021-0597
Citation Manager Formats
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Kailash Krishnan, Zhe Kang Law, Jatinder S Minhas, Philip M Bath, Thompson G Robinson, Nikola Sprigg, Akash Mavilakandy, Timothy J England, David Eveson, Amit Mistri, Jesse Dawson, Jason P Appleton
Clinical Medicine Sep 2022, 22 (5) 449-454; DOI: 10.7861/clinmed.2021-0597
Jump to section
- Article
- ABSTRACT
- Introduction
- Risk of recurrent stroke
- Aspirin
- Clopidogrel
- Dipyridamole
- Aspirin plus clopidogrel in minor stroke and TIA
- Aspirin plus dipyridamole versus clopidogrel
- Ticagrelor
- Ticagrelor plus aspirin in minor stroke and TIA
- Ticagrelor in addition to aspirin in minor stroke and TIA?
- Recurrent stroke on antiplatelets
- Clinical guidelines
- Conclusion and future directions
- Key points
- Supplementary material
- Conflicts of interest
- References
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.